Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Animal model molecular biology testing delivers accurate genotyping, pathogen screening, and gene expression analysis for laboratory animals, safeguarding the genetic integrity and health status that reliable preclinical research depends on. This technical guide explains the main sample types, testing items, analytical methods, and quality standards commonly applied to molecular testing of animal models in accredited third-party laboratories.

Technical Overview

Animal models such as mice, rats, rabbits, canines, and zebrafish are indispensable tools in drug discovery, toxicology, and biomedical research. The scientific value of any study built on these models depends on two fundamental attributes: genetic authenticity and a defined microbiological status. Molecular biology testing addresses both requirements by verifying the genotype of genetically modified lines, monitoring pathogens at the nucleic acid level, and quantifying gene expression changes associated with disease or treatment.

Modern molecular platforms, including conventional PCR, real-time quantitative PCR (qPCR), reverse transcription PCR (RT-PCR), digital PCR (dPCR), Sanger sequencing, and next-generation sequencing (NGS), enable sensitive, specific, and rapid analysis of DNA and RNA extracted from very small tissue samples. Testing is typically performed in ISO/IEC 17025-accredited third-party laboratories and follows recognized national and international frameworks, such as the laboratory animal microbiological and parasitological monitoring standards GB 14922 and the GB/T 14926 series, together with applicable method validation and quality assurance requirements.

Testing Samples

Tissue Biopsies for Genotyping

Small tissue specimens are the primary material for genetic identification of rodent models. Accepted sample types include tail tip biopsies (typically 2 to 5 mm), ear notches or punches collected during routine identification, toe biopsies obtained within the age window permitted by animal welfare requirements, yolk sac or amniotic membranes from neonates, hair follicles with intact roots, and dried blood spots on nucleic acid preservation cards. Samples may be shipped fresh on ice, frozen, in ethanol, or dried on preservation cards.

Health Monitoring Specimens

For microbiological status confirmation of specific pathogen free (SPF) colonies, common specimens include oral, nasal, and anal swabs; fur and skin swabs; fresh fecal pellets; whole blood and serum; and tissue homogenates from sentinel or index animals. Exhaust air dust filters and soiled bedding from sentinels are also widely used for colony-level surveillance in individually ventilated cage systems.

Cells, Tissues, and Body Fluids Derived from Animal Models

Biological materials obtained from animal models, including primary cells, xenograft and allograft tumors, organoids, blood, bronchoalveolar lavage fluid, cerebrospinal fluid, urine, and tissue lysates, are tested for adventitious agents, residual vector sequences, transgene stability, and expression biomarkers before use in downstream experiments.

Environmental and Husbandry Samples

Swabs from cage interiors, racks, doors, and changing stations, as well as feed, bedding, and drinking water specimens, are analyzed to verify barrier facility hygiene and to trace contamination sources during outbreak investigations.

Testing Items

Core molecular testing items for animal models typically include the following:

  • Genotyping of knockout, knock-in, conditional (floxed), transgenic, and humanized models, including zygosity determination.
  • Verification of CRISPR/Cas9 and other genome editing events, including small insertions and deletions and integration junction confirmation.
  • Copy number variation (CNV) analysis of transgenes and targeted constructs.
  • SPF pathogen screening panels covering rodent viruses such as murine norovirus, mouse hepatitis virus, murine parvoviruses, Theiler's murine encephalomyelitis virus, and Sendai virus, as well as bacteria including Helicobacter species, Pasteurella pneumotropica, and cilia-associated respiratory bacillus.
  • Mycoplasma detection in cells, tissues, and derived biological products intended for animal inoculation.
  • Gene expression profiling and mRNA quantification of therapeutic targets, biomarkers, cytokines, and knockdown or overexpression constructs.
  • Viral vector quality testing, including genome titer determination for AAV, lentiviral, and adenoviral vectors and assessment of residual host-cell nucleic acids.
  • Species and strain identification and cell line origin confirmation using mitochondrial DNA barcoding or microsatellite and STR marker panels.
  • Metagenomic NGS screening for unexplained disease or unexpected agents not covered by routine monitoring panels.

Testing Methods

Conventional PCR with Gel Electrophoresis

Endpoint PCR followed by agarose gel visualization remains the standard approach for routine genotyping. Multiplexed primer sets distinguish wild-type, mutant, and conditional alleles in a single reaction, delivering clear banding patterns suitable for breeding and colony management decisions.

Real-Time Quantitative PCR (qPCR)

qPCR using hydrolysis probes or SYBR Green chemistry provides sensitive detection and precise quantification of pathogens, transgenes, and expression targets. Absolute quantification with calibrated standard curves supports viral load determination, while relative quantification using validated reference genes is applied to expression analysis.

Reverse Transcription PCR (RT-PCR and RT-qPCR)

RNA-based assays detect RNA viruses, replicating agents, and messenger RNA transcripts. Incorporation of internal amplification controls and DNase treatment guards against false-negative extraction failures and genomic DNA carryover.

Digital PCR (dPCR)

Droplet or chip-based digital PCR partitions each reaction into thousands of individual units, enabling absolute quantification without standard curves and resolving low-copy targets, rare alleles, and subtle copy number differences with high precision.

Sequencing Confirmation

Sanger sequencing confirms the precise sequence of edited loci, integration sites, and PCR amplicons, while targeted NGS panels and metagenomic sequencing provide broader coverage for multiplexed pathogen detection, vector integrity assessment, and complex microbial community profiling.

Isothermal Amplification

LAMP and recombinase polymerase amplification assays generate results at a constant temperature within 15 to 40 minutes and are valuable for rapid on-site screening of high-risk agents or colony triage during quarantine.

Quality Assurance and Controls

Validated workflows incorporate positive, negative, and no-template controls; internal endogenous controls; physical separation of pre-PCR and post-PCR areas; and dUTP and uracil-N-glycosylase carryover prevention. Accredited third-party laboratories structure these quality systems in accordance with ISO/IEC 17025 requirements and, where applicable, relevant GB/T method standards.

Applications

  • Preclinical drug development: confirming model genotype and baseline gene expression to ensure pharmacology and safety data are reproducible and translatable.
  • Vaccine and antiviral research: quantifying challenge virus loads in tissues to evaluate efficacy, shedding, and transmission endpoints.
  • Gene and cell therapy: validating editing efficiency, vector biodistribution, and persistence of therapeutic constructs in treated animals.
  • Oncology research: monitoring tumor engraftment, confirming cell line identity, and excluding rodent pathogens in patient-derived and cell line-derived xenograft programs.
  • Facility management: supporting routine SPF surveillance, barrier integrity assessment, and outbreak investigation for animal colonies.
  • Regulatory and publication support: generating auditable genotyping and pathogen status reports that satisfy reviewers, inspectors, and study sponsors.

FAQ

How should tail biopsy samples be collected and transported?

Collect 2 to 5 mm of tail tip using sterile instruments, avoid cross-contamination between animals, and transfer tissue into individually labeled tubes. Samples may be shipped frozen, in 70 to 95 percent ethanol, air-dried, or on nucleic acid preservation cards under ambient conditions, and every specimen must be uniquely identified with lineage information.

What sensitivity can molecular assays achieve?

Well-optimized qPCR assays routinely reach single-digit copy detection per reaction with appropriate controls, and digital PCR extends reliable quantification to low-copy targets. Actual limits of detection depend on the sample matrix, extraction efficiency, and the validated performance characteristics of each assay.

How long does genotyping take?

Standard PCR genotyping workflows typically return results within 2 to 5 working days after sample receipt, while projects involving sequencing confirmation, novel assay design, or copy number analysis by digital PCR may require additional turnaround time.

Can environmental samples replace direct animal testing?

Exhaust air dust and soiled bedding testing offers a sensitive, animal-sparing complement to direct sampling and is widely accepted for routine colony surveillance; direct animal or sentinel testing is still recommended when investigating clinical signs or confirming clearance after an outbreak.

What does a typical test report include?

Reports document sample identity, extraction and assay methods, amplification curves or gel images, control results, Ct or copy number values, allele calls or pathogen status, and interpretations reviewed and signed by qualified personnel, providing traceable evidence for study records, audits, and regulatory submissions.